{"id":"NCT01763905","sponsor":"Amgen","briefTitle":"Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2","officialTitle":"A Double-blind, Randomized, Multicenter Study to Evaluate Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01-24","primaryCompletion":"2013-11-19","completion":"2013-11-19","firstPosted":"2013-01-09","resultsPosted":"2015-12-22","lastUpdate":"2020-07-20"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Placebo to Evolocumab","otherNames":[]},{"type":"DRUG","name":"Ezetimibe","otherNames":["Zetia"]},{"type":"DRUG","name":"Placebo to Ezetimibe","otherNames":[]}],"arms":[{"label":"Ezetimibe (Q2W)","type":"ACTIVE_COMPARATOR"},{"label":"Ezetimibe (QM)","type":"ACTIVE_COMPARATOR"},{"label":"Evolocumab Q2W","type":"EXPERIMENTAL"},{"label":"Evolocumab QM","type":"EXPERIMENTAL"}],"summary":"The primary objective was to evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab every 2 weeks (Q2W) and monthly (QM), compared with ezetimibe, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in hypercholesterolemic adults unable to tolerate an effective dose of a statin (HMG-CoA (5-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors).","primaryOutcome":{"measure":"Percent Change From Baseline in LDL-C at Week 12","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Ezetimibe (Q2W)","deltaMin":-18.08,"sd":2.52},{"arm":"Ezetimibe (QM)","deltaMin":-15.05,"sd":2.13},{"arm":"Evolocumab Q2W","deltaMin":-56.14,"sd":1.91},{"arm":"Evolocumab QM","deltaMin":-52.6,"sd":1.58}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":58,"countries":["United States","Australia","Belgium","Canada","Denmark","France","Germany","Hong Kong","Netherlands","Poland","South Africa","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["28249876","29736889","30073585","29353350","29768954","24477778","24694531","30755061","30120772","32114889","32564340"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":51},"commonTop":["Myalgia","Headache","Fatigue","Muscle spasms","Nausea"]}}